Back to List View Graph View

Tumor microenvironment

The tumor microenvironment (TME) refers to the complex, dynamic ecosystem surrounding and infiltrating a malignant tumor, comprising not only cancer cells but also a heterogeneous mixture of stromal cells, immune cells, extracellular matrix components, blood vessels, and soluble signaling molecules.

Where the papers sit

10 papers from the last 6 months study tumor microenvironment directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 3 human data · 5 preclinical · 2 unclassified

Themes 3 themes

  • Molecular Drivers of Therapy Resistance

    Therapy resistance is being mapped through chromatin architecture, ubiquitination, metabolism, and innate immune sensing across several cancers. Single-cell and multi-omic analyses seek cell-state signatures for LUAD evolution, neuroendocrine prostate cancer, and KRAS-mutant lung adenocarcinoma. Galactose reprogramming and cGAS-STING activation are being proposed as routes to restore anti-PD-1 sensitivity, while the gene signatures remain largely hypothesis-generating. The shared direction is toward mechanism-based biomarkers and combination treatments, not a single established intervention.

    4 papers · 40%

  • Preclinical Microenvironment Remodeling

    Stromal and immune remodeling is being paired with localized or nanomedicine-based treatment to make solid tumors more responsive. Extracellular-vesicle photoimmunotherapy and cuproptosis-oriented materials target the extracellular matrix and immune suppression in pancreatic ductal adenocarcinoma. HIFU and inhalable nitric oxide add physical or gas-based ways to alter the local niche and stimulate antitumor immunity. The evidence remains preclinical, and the relative contributions of stromal disruption, direct tumor killing, and immune activation are unresolved.

    3 papers · 30%

  • Cancer Immune Modulation

    Immune activity in tumors is being treated as a metabolic and behavioral system rather than a fixed property of cancer cells. Tumor-derived antioxidants can deprive T cells of reactive oxygen species, while PI3Kγ inhibition and membrane-active peptides aim to reprogram suppressive macrophage-rich niches. Physical activity is linked to immune-cell infiltration in non-metastatic colon cancer, but the association does not establish treatment benefit. The field is moving toward combining host-level interventions with microenvironment-directed immunotherapy.

    3 papers · 30%

Papers

The 10 papers from the last 6 months that study tumor microenvironment directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Molecular Drivers of Therapy Resistance (4)
  1. "Yong" syndrome-cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. Journal for immunotherapy of cancer · 4 Aug 2026 PMID 42552062
  2. Targeting galactose metabolic reprogramming overcomes immunotherapy resistance in KRAS-mutant lung adenocarcinoma: Integrative multi-omics and machine learning approaches. Translational oncology · 6 Jul 2026 PMID 42407377
  3. Ubiquitination-anchored signature defines neuroendocrine prostate cancer: hub genes and single-cell ecosystem insights from integrated bioinformatics analysis of public transcriptomic datasets. The aging male : the official journal of the International Society for the Study of the Aging Male · 6 Jun 2026 PMID 42249833
  4. 3D chromatin architecture-related genes orchestrate LUAD evolution and therapy resistance: insights from integrative machine learning and spatial single-cell mapping. Functional & integrative genomics · 4 Jun 2026 PMID 42240917
Preclinical Microenvironment Remodeling (3)
  1. An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
  2. Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mouse model. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 18 Aug 2026 PMID 42609051
  3. Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models. Cell reports. Medicine · 3 Jun 2026 PMID 42235518
Cancer Immune Modulation (3)
  1. Association of objectively assessed physical activity with immune cell infiltration of the tumor microenvironment in non-metastatic colon cancer. International journal of colorectal disease · 10 Sept 2026 PMID 42720727
  2. Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species. Science (New York, N.Y.) · 3 Sept 2026 PMID 42691162
  3. pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy. Biomaterials science · 17 Aug 2026 PMID 42605855

By study type

Human data, design not indexed (3)
  1. Association of objectively assessed physical activity with immune cell infiltration of the tumor microenvironment in non-metastatic colon cancer. International journal of colorectal disease · 10 Sept 2026 PMID 42720727
  2. "Yong" syndrome-cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. Journal for immunotherapy of cancer · 4 Aug 2026 PMID 42552062
  3. 3D chromatin architecture-related genes orchestrate LUAD evolution and therapy resistance: insights from integrative machine learning and spatial single-cell mapping. Functional & integrative genomics · 4 Jun 2026 PMID 42240917
Preclinical: animal, cell and lab studies (5)
  1. An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
  2. Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species. Science (New York, N.Y.) · 3 Sept 2026 PMID 42691162
  3. Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mouse model. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 18 Aug 2026 PMID 42609051
  4. pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy. Biomaterials science · 17 Aug 2026 PMID 42605855
  5. Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models. Cell reports. Medicine · 3 Jun 2026 PMID 42235518
Unclassified: not yet indexed with MeSH (2)
  1. Targeting galactose metabolic reprogramming overcomes immunotherapy resistance in KRAS-mutant lung adenocarcinoma: Integrative multi-omics and machine learning approaches. Translational oncology · 6 Jul 2026 PMID 42407377
  2. Ubiquitination-anchored signature defines neuroendocrine prostate cancer: hub genes and single-cell ecosystem insights from integrated bioinformatics analysis of public transcriptomic datasets. The aging male : the official journal of the International Society for the Study of the Aging Male · 6 Jun 2026 PMID 42249833